S
Snjezana Miocic
Researcher at International Centre for Genetic Engineering and Biotechnology
Publications - 10
Citations - 1084
Snjezana Miocic is an academic researcher from International Centre for Genetic Engineering and Biotechnology. The author has contributed to research in topics: Dilated cardiomyopathy & Cardiomyopathy. The author has an hindex of 5, co-authored 10 publications receiving 1038 citations.
Papers
More filters
Journal ArticleDOI
Lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement.
Gary Brodsky,Francesco Muntoni,Snjezana Miocic,Gianfranco Sinagra,Caroline Sewry,Luisa Mestroni +5 more
TL;DR: The lamin A/C gene was examined in the MDDC1 family and a single nucleotide deletion was identified within exon 6, and all affected individuals were found to be heterozygous for this deletion.
Journal ArticleDOI
Familial dilated cardiomyopathy: evidence for genetic and phenotypic heterogeneity. Heart Muscle Disease Study Group.
Luisa Mestroni,C. Rocco,Dario Gregori,Gianfranco Sinagra,A. Di Lenarda,Snjezana Miocic,Matteo Vatta,Bruno Pinamonti,Francesco Muntoni,Alida L.P. Caforio,WJ McKenna,Arturo Falaschi,Mauro Giacca,Camerini +13 more
TL;DR: Familial dilated cardiomyopathy is frequent, cannot be predicted on a clinical or morphologic basis and requires family screening for identification, and initial molecular genetic data indicate that multiple genes and pathogenetic mechanisms can lead to FDC.
Journal ArticleDOI
Familial dilated cardiomyopathy: Evidence for genetic and phenotypic heterogeneity
Luisa Mestroni,C. Rocco,Dario Gregori,Gianfranco Sinagra,Andrea Di Lenarda,Snjezana Miocic,Matteo Vatta,Bruno Pinamonti,Francesco Muntoni,Alida L.P. Caforio,William J. McKenna,Arturo Falaschi,Mauro Giacca,Fulvio Camerini +13 more
TL;DR: In this article, the authors evaluated the characteristics, mode of inheritance and etiology of familial dilated cardiomyopathy (FDC) and found that only a younger age and a higher ejection fraction (p = 0.03) could clinically distinguish FDC patients from those with sporadic DCM.
Journal ArticleDOI
α-Myosin Heavy Chain A Sarcomeric Gene Associated With Dilated and Hypertrophic Phenotypes of Cardiomyopathy
Elisa Carniel,Matthew R.G. Taylor,Gianfranco Sinagra,Andrea Di Lenarda,Lisa Ku,Pamela R. Fain,Mark M. Boucek,Jean Cavanaugh,Snjezana Miocic,Dobromir Slavov,Sharon L. Graw,Jennie Feiger,Xiao Zhong Zhu,Dmi Dao,Debra A. Ferguson,Michael R. Bristow,Luisa Mestroni +16 more
TL;DR: It is suggested that mutations in MYH6 may cause a spectrum of phenotypes ranging from DCM to HCM, and the DCM carrier phenotype was characterized by late onset, whereas the HCM phenotype was characterize by progression toward dilation, left ventricular dysfunction, and refractory heart failure.
Journal ArticleDOI
Advances in molecular genetics of dilated cardiomyopathy
TL;DR: In clinical surveys, familial dilated cardiomyopathy (FDC) has been demonstrated in 20% to 30% of patients, and in these patients, the cause of the disease lies at the DNA level.